达英与二甲双胍联合应用于肥胖型多囊卵巢综合症的效果观察

发布时间：2018-06-06 13:49

本文选题：达英 + 二甲双胍　；参考：《实用妇科内分泌杂志(电子版)》2016年17期

【摘要】：目的探讨达英与二甲双胍联合应用于肥胖型多囊卵巢综合症的效果。方法选取2014年10月~2015年10月我院收治的肥胖型多囊卵巢综合症患者50例的临床资料进行回顾性分析,按照门诊序号平均分成两组,对照组给予药物达英治疗,观察组在此基础上联合二甲双胍进行治疗,观察两组患者的性激素、BMI、血脂水平等指标,并对疗效进行评价。结果治疗前两组患者的性激素、BMI、血脂水平等指标,差异无统计学意义(P0.05),治疗后观察组性激素、BMI、血脂水平等指标明显优于对照组,差异有统计学意义(P0.05)。观察组总有效率为92%,对照组总有效率为88%,观察组明显高于对照组,达英联合二甲双胍治疗肥胖型多囊卵巢综合症患者效果显著。结论达英与二甲双胍联合应用在肥胖型多囊卵巢综合症患者治疗中可以有效地控制性激素和血脂水平,使得BMI指数下降程度良好,疗效显著,治疗方法值得临床借鉴和推广使用。
[Abstract]:Objective to investigate the effect of dibumin combined with metformin in obese polycystic ovary syndrome (PCOS). Methods the clinical data of 50 patients with obese polycystic ovary syndrome from October 2014 to October 2015 were retrospectively analyzed. The observation group was treated with metformin on this basis, the sex hormone BMIand blood lipid level were observed, and the curative effect was evaluated. Results there was no significant difference in sex hormone BMIand lipid level between the two groups before treatment. After treatment, the indexes of sex hormone BMIand blood lipid in the observation group were significantly better than those in the control group, and the difference was statistically significant (P 0.05). The total effective rate of the observation group was 92 and the total effective rate of the control group was 88. The observation group was significantly higher than the control group. Conclusion the combination of dibumin and metformin in the treatment of obese patients with polycystic ovary syndrome can effectively control the levels of sex hormones and blood lipids, and make the BMI index decrease well, and the curative effect is remarkable. The treatment method is worthy of clinical reference and popularization.
【作者单位】：苏州市吴中人民医院妇产科;
【分类号】：R711.75

【相似文献】